Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 10, 2017
The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry
J M P A van den Reek, M M B Seyger, P P M van Lümig, et al.
The British Journal of Dermatology
|
May 15, 2008
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies
R G van Lingen, J E M Körver, P C M van de Kerkhof, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2025
Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy
H S A Tingen, M Berends, A Tubben, et al.
Acta Dermato-Venereologica
|
November 16, 2020
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
Selma Atalay, Juul M P A van den Reek, Marisol E Otero, et al.
Cell Host & Microbe
|
September 26, 2017
Dietary Manganese Promotes Staphylococcal Infection of the Heart
Lillian J Juttukonda, Evelien T M Berends, Joseph P Zackular, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 10, 2019
Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry
L S van der Schoot, J M P A van den Reek, J M M Groenewoud, et al.
The British Journal of Dermatology
|
March 19, 2016
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry
J Zweegers, J M P A van den Reek, P C M van de Kerkhof, et al.
Cell Host & Microbe
|
June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design
Nina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
The British Journal of Dermatology
|
September 1, 2016
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry
J Zweegers, J M M Groenewoud, J M P A van den Reek, et al.
Acta Dermato-Venereologica
|
March 31, 2022
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
Marloes E Van Muijen, Sarah E Thomas, Hans M M Groenewoud, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 10, 2017
The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry
J M P A van den Reek, M M B Seyger, P P M van Lümig, et al.
The British Journal of Dermatology
|
May 15, 2008
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies
R G van Lingen, J E M Körver, P C M van de Kerkhof, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2025
Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy
H S A Tingen, M Berends, A Tubben, et al.
Acta Dermato-Venereologica
|
November 16, 2020
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
Selma Atalay, Juul M P A van den Reek, Marisol E Otero, et al.
Cell Host & Microbe
|
September 26, 2017
Dietary Manganese Promotes Staphylococcal Infection of the Heart
Lillian J Juttukonda, Evelien T M Berends, Joseph P Zackular, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 10, 2019
Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry
L S van der Schoot, J M P A van den Reek, J M M Groenewoud, et al.
The British Journal of Dermatology
|
March 19, 2016
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry
J Zweegers, J M P A van den Reek, P C M van de Kerkhof, et al.
Cell Host & Microbe
|
June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design
Nina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
The British Journal of Dermatology
|
September 1, 2016
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry
J Zweegers, J M M Groenewoud, J M P A van den Reek, et al.
Acta Dermato-Venereologica
|
March 31, 2022
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
Marloes E Van Muijen, Sarah E Thomas, Hans M M Groenewoud, et al.
Page
of 6